Explore more Articles in

Stock Sectors

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness...

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year,...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities,...
BioTech

Gilead’s HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences Inc GILD is facing mounting pressure to price its long-acting HIV prevention drug, lenacapavir, affordably as it prepares for U.S. regulatory approval...
BioTech

FDA Introduces Tumor Board-Style Reviews For Faster Drug Decisions

The U.S. Food and Drug Administration (FDA) announced its Commissioner's National Priority Voucher (CNPV) program.What Happened: The FDA aims to modernize its regulatory framework...
BioTech

Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps – Mineralys Therapeutics (NASDAQ:MLYS)

Mineralys Therapeutics, Inc. MLYS revealed topline data Tuesday from its Phase 2 Explore-CKD trial, which evaluated the safety and efficacy of 25 mg of...
BioTech

AbbVie’s Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes – AbbVie (NYSE:ABBV)

AbbVie Inc ABBV on Monday announced an update from the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine for newly diagnosed...
Energy Stocks

The Energy Report: Operation Rising Lion and Operation Rising Prices

Israel’s military operation against Iran’s nuclear proliferation is called ”Operation Rising Lion” but they can also call it “Operation Rising Oil Prices” as it...
BioTech

Why Is Dyne Therapeutics Stock Trading Lower On Tuesday? – Dyne Therapeutics (NASDAQ:DYN)

Dyne Therapeutics, Inc. DYN stock is trading lower after the company announced on Tuesday that it had revised the ongoing Registrational Expansion Cohort in...
1...242526...29Page 25 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.